Success Metrics

Active Trials

0(0%)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

4(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Other(4)

Detailed Status

unknown4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 1

Trials by Phase

Phase 14 (100.0%)

Trials by Status

unknown4100%

Recent Activity

0 active trials

Showing 4 of 4

unknownphase_1

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy

NCT02439541

unknownphase_1

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis

NCT02442037

unknownphase_1

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury

NCT02444858

unknownphase_1

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Acute Lung Injury

NCT02444455

Clinical Trials (4)

Showing 4 of 4 trials

NCT02439541Phase 1

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy

Unknown

NCT02442037Phase 1

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis

Unknown

NCT02444858Phase 1

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury

Unknown

NCT02444455Phase 1

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Acute Lung Injury

Unknown

All 4 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 4